fluorodopa f 18 has been researched along with Argentaffinoma in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 6 (42.86) | 29.6817 |
2010's | 7 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ben Abdelghani, M; Blondet, C; El Ghannudi, S; Germain, P; Imperiale, A; Romain, B | 1 |
Santhanam, P; Taïeb, D | 1 |
Acevedo-Báñez, I; García-Gómez, FJ; Mangas-Cruz, MA; Muñiz-Grijalvo, O; Tirado-Hospital, JL | 1 |
Goichot, B; Heimburger, C; Helali, M; Imperiale, A; Rohr, S | 1 |
de Vries, EG; Koornstra, JJ; Porte, RJ | 1 |
Brouwers, AH; de Vries, EG; Fiebrich, HB; Koopmans, KP | 1 |
Cavet, M; Dousset, B; Faraggi, M; Hignette, C; Modis, C; Richard, B; Tenenbaum, F | 1 |
Brouwers, AH; de Jong, JR; de Vries, EG; Dierckx, RA; Fiebrich, HB; Kema, IP; Koopmans, KP; Links, TP; Sluiter, W; Walenkamp, AM | 1 |
Chirakal, R; Gulenchyn, KY; Jager, PL; Major, P; Reid, R; Yakemchuk, VN | 1 |
de Vries, EG; Elsinga, PH; Jager, PL; Kema, IP; Koopmans, KP; Neels, OC; Sluiter, WJ; van der Horst-Schrivers, AN | 1 |
Aide, N; de Beco, V; Grahek, D; Grangé, JD; Gutman, F; Kerrou, K; Lotz, JP; Montravers, F; Ruszniewski, P; Talbot, JN | 1 |
Balard, M; de Beco, V; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Nataf, V; Talbot, JN | 1 |
Brousseau, M; Cahouet, A; Dubois, S; Girault, S; Illouz, F; Lacoeuille, F; Morel, O; Picquet, J; Rodien, P; Rohmer, V | 1 |
Hoegerle, S; Kraft, A; Moser, E; Nitzsche, EU; Schneider, B | 1 |
1 review(s) available for fluorodopa f 18 and Argentaffinoma
Article | Year |
---|---|
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2014 |
13 other study(ies) available for fluorodopa f 18 and Argentaffinoma
Article | Year |
---|---|
Cardiac Metastases of Small-Bowel Carcinoid
Topics: Adult; Carcinoid Heart Disease; Carcinoid Tumor; Dihydroxyphenylalanine; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2019 |
18F-DOPA vs. 18F-FDG PET/CT in the ectopic ACTH syndrome due to pulmonary carcinoid tumor.
Topics: ACTH Syndrome, Ectopic; Adult; Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pituitary ACTH Hypersecretion; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2015 |
Small Bowel Carcinoid: The "Dancing Bowel Sign" on 18F-FDOPA PET/CT.
Topics: Adult; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography | 2016 |
Improvements in small bowel carcinoid diagnosis and staging: 18F-DOPA PET, capsule endoscopy and double balloon enteroscopy.
Topics: Capsule Endoscopy; Carcinoid Tumor; Cone-Beam Computed Tomography; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Jejunal Neoplasms; Laparotomy; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography | 2009 |
Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
Topics: Adenocarcinoma; Aged; Carcinoid Tumor; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2009 |
[Recurrent carcinoid tumor and 18F-DOPA PET].
Topics: Biomarkers, Tumor; Carcinoid Tumor; Colonic Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2010 |
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour.
Topics: Adolescent; Adult; Aged; Biological Transport; Carcinoid Tumor; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2011 |
PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.
Topics: Adult; Aged; Aged, 80 and over; Canada; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Intestinal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity; Somatostatin; Tomography, X-Ray Computed | 2012 |
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study.
Topics: Adult; Aged; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Somatostatin; Tomography, X-Ray Computed | 2006 |
Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
Topics: Adult; Aged; Carcinoid Tumor; Digestive System Neoplasms; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Somatostatin | 2006 |
Safety of 18F-DOPA injection for PET of carcinoid tumor.
Topics: Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Injections, Intravenous; Malignant Carcinoid Syndrome; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
A Pulmonary adrenocorticotropin-secreting carcinoid tumor localized by 6-Fluoro-[18F]L-dihydroxyphenylalanine positron emission/computed tomography imaging in a patient with Cushing's syndrome.
Topics: Adolescent; Adrenocorticotropic Hormone; Carcinoid Tumor; Cushing Syndrome; Dihydroxyphenylalanine; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography.
Topics: Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Receptors, Somatostatin; Somatostatin; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |